CA1225596A - Procede de preparation de composes pharmaceutiques a delitement progressif ayant une forte teneur en ingredient actif - Google Patents

Procede de preparation de composes pharmaceutiques a delitement progressif ayant une forte teneur en ingredient actif

Info

Publication number
CA1225596A
CA1225596A CA000447906A CA447906A CA1225596A CA 1225596 A CA1225596 A CA 1225596A CA 000447906 A CA000447906 A CA 000447906A CA 447906 A CA447906 A CA 447906A CA 1225596 A CA1225596 A CA 1225596A
Authority
CA
Canada
Prior art keywords
active ingredient
tablets
release
process according
sustained release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000447906A
Other languages
English (en)
Inventor
Pal Fekete
Ilona Nee Baumgartner Bor
Katalin Nee Sumeg Zukovics
Zoltan Toth
Eva Tamas
Denes Bezzegh
Tibor Kovacs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to CA000447906A priority Critical patent/CA1225596A/fr
Application granted granted Critical
Publication of CA1225596A publication Critical patent/CA1225596A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
CA000447906A 1984-02-21 1984-02-21 Procede de preparation de composes pharmaceutiques a delitement progressif ayant une forte teneur en ingredient actif Expired CA1225596A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000447906A CA1225596A (fr) 1984-02-21 1984-02-21 Procede de preparation de composes pharmaceutiques a delitement progressif ayant une forte teneur en ingredient actif

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000447906A CA1225596A (fr) 1984-02-21 1984-02-21 Procede de preparation de composes pharmaceutiques a delitement progressif ayant une forte teneur en ingredient actif

Publications (1)

Publication Number Publication Date
CA1225596A true CA1225596A (fr) 1987-08-18

Family

ID=4127248

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000447906A Expired CA1225596A (fr) 1984-02-21 1984-02-21 Procede de preparation de composes pharmaceutiques a delitement progressif ayant une forte teneur en ingredient actif

Country Status (1)

Country Link
CA (1) CA1225596A (fr)

Similar Documents

Publication Publication Date Title
US4748023A (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
Dhopeshwarkar et al. Evaluation of xanthan gum in the preparation of sustained release matrix tablets
US4708874A (en) Devices for the controlled release of active substances, as well as process for the preparation thereof
EP0231826B1 (fr) Comprimé de théophylline à libération retardée
US6066334A (en) Use of redispersible polymer powders or polymer granules as binders for producing solid pharmaceutical presentations
JPH07509479A (ja) 長期間にわたって２段階で放出する形態を有する固体の薬剤投与形態およびその製造
CA2212309C (fr) Formes posologiques orales solides a liberation prolongee de medicaments faiblement solubles dans l'eau
Haslam et al. Tableting of controlled release multiparticulates, the effect of millisphere size and protective overcoating
GB2123291A (en) Suloctidil compositions
CA1225596A (fr) Procede de preparation de composes pharmaceutiques a delitement progressif ayant une forte teneur en ingredient actif
AU728754B2 (en) Compact member comprising a plurality of porous cellulose matrices, (PCMs), method of manufacturing and use thereof
US6322813B1 (en) Compact member, method of manufacturing and use thereof
JP2745232B2 (ja) トリメブチンを基剤とした徐放性組成物とその製造方法
Fassihi Kinetics of drug release from solid matrices: Effect of compaction pressure
Westerberg et al. Physicochemical aspects of drug release. XII. The effect of some carrier particle properties and lubricant admixture on drug dissolution from tableted ordered mixtures
Van Oudtshoorn et al. The influence of compression and formulation on the hardness, disintegration, dissolution, absorption and excretion of sulphadimidine tablets
IE42952B1 (en) Tablet formulation
EP0222883A1 (fr) Procedes et compositons de theophylline a liberation entretenue
Eshra et al. Preparation and evaluation of slow-release pan-coated indomethacin granules
Kitamori et al. Evaluation of changes in drug particle size during tableting by measurement of dissolution of disintegrated tablets
Wagner Biopharmaceutics: 15. Disintegration of Dosage Forms in Vitro and Part V
Madan Autohated Deterhination of Dissolution Rate: Effect of Particle Size Distribution
Dedhiya et al. Relationship between compression profile and physical properties of lithium carbonate formulation
Al-Meshal et al. Communications Evaluation of Egg Albumin as a Filler for Prolonged Release Direct Compressed Tablets
Chalmers Formulation Studies on Oxytetracycline Dihydrate

Legal Events

Date Code Title Description
MKEX Expiry